Michelle represents life sciences clients in patent litigation disputes across a wide range of pharmaceutical technologies, including biologics and small molecules. She is experienced in Hatch-Waxman litigation as well as traditional patent infringement disputes spanning formulation, drug product and method of treatment claims. Michelle has represented clients in all stages of litigation, including claim construction, discovery, trial and appeal.

Michelle also counsels clients on patent strategy, IP portfolio evaluation and an assortment of regulatory matters.